A 3D electrochemical biosensor based on Super-Aligned Carbon NanoTube array for point-of-care uric acid monitoring

Muqun Yang,Han Wang,Peng Liu,Jing Cheng
DOI: https://doi.org/10.1016/j.bios.2021.113082
IF: 12.545
2021-05-01
Biosensors and Bioelectronics
Abstract:<p>Uric acid analysis is extremely important for gout prognosis, diagnosis and treatment. Previous technologies either lack specificity or exhibit poor performance, and thus could not meet the need of Point-of-Care (POC) uric acid monitoring. Here we present for the first time, a novel electrochemical biosensor based on 3D Super-Aligned Carbon NanoTube (SACNT) array to facilitate POC uric acid monitoring. The working electrode of the biosensor is composed of an orderly 3D SACNT array immobilized with uricase through a precipitation and crosslinking procedure. Such biosensor possesses a higher enzyme density, significantly larger contact area with reactants and could maintain the intact SACNT structure and its excellent conductivity after modification. The developed 3D SACNT array electrochemical biosensor benefits from high specific surface area, high electro-catalytic activity and large contact area with analytes, and demonstrates high sensitivity of 518.8 μA/(mM⋅cm<sup>2</sup>), wide linear range of 100 - 1000 μM and low limit of detection of 1 μM for uric acid. Dynamic uric acid monitoring has been achieved using the presented biosensor. And the obtained results in serum samples had no significant difference compared with those obtained using the FDA-approved electrochemical analyzer (Paired T-test, p &gt; 0.05). These demonstrated that the technology can potentially be applied in POC monitoring of other biomolecules to improve prognosis, diagnosis and treatment outcomes of metabolic diseases.</p>
biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the rapid, accurate, and portable point - of - care (POC) uric acid detection in clinical practice. Specifically, the researchers developed an electrochemical biosensor based on three - dimensional super - aligned carbon nanotube arrays (3D SACNT) for the real - time monitoring of uric acid. Traditional uric acid detection methods either lack specificity or have poor performance and cannot meet the requirements of POC uric acid monitoring. The new electrochemical biosensor introduced in this paper uses an ordered 3D SACNT array as the working electrode and immobilizes uricase through precipitation and cross - linking processes, achieving uric acid detection with high sensitivity, a wide linear range, and a low detection limit, thus providing a new solution for POC uric acid monitoring. ### Main contributions 1. **High sensitivity and wide linear range**: This biosensor exhibits a high sensitivity of 518.8 μA/(mM·cm²), a wide linear range of 100–1000 μM, and a low detection limit of 1 μM. 2. **Dynamic monitoring ability**: This biosensor can achieve dynamic monitoring of uric acid, and there is no significant difference between the detection results in serum samples and those of the FDA - approved electrochemical analyzer (paired T - test, p > 0.05). 3. **Structural advantages**: The 3D SACNT array has a high specific surface area, high electrocatalytic activity, and a large contact area. These characteristics enable the biosensor to exhibit excellent performance in detecting uric acid. 4. **Simple preparation**: Immobilizing uricase through precipitation and cross - linking processes avoids the destruction of the carbon nanotube structure by strong oxidants in traditional methods and maintains the intact structure and excellent conductivity of SACNT. ### Significance This research not only provides an effective tool for POC monitoring of uric acid but also has potential application prospects for the clinical prognosis, diagnosis, and treatment of other metabolites such as glucose and lactic acid. Through this portable, rapid, and highly sensitive detection method, metabolic diseases can be better managed and the treatment effect of patients can be improved.